Aortic Vascular Smooth Muscle Cell Proliferation Attribute
Introduction
Aortic vascular smooth muscle cells (VSMCs) are fundamental components of the aorta, crucial for maintaining its structural integrity and regulating blood flow. Under normal physiological conditions, these cells typically exist in a quiescent, contractile state. However, in response to various pathological stimuli, VSMCs can undergo a phenotypic shift, leading to their increased proliferation and migration. This process, known as aortic vascular smooth muscle cell proliferation, is a key mechanism in vascular remodeling, which underlies the development and progression of many cardiovascular diseases.
Biological Basis
The proliferation of aortic vascular smooth muscle cells is a highly regulated biological process governed by complex genetic and molecular pathways. Studies have indicated that telomerase activity is upregulated in the aorta of spontaneous hypertensive rats, and its downregulation is associated with the arrest of VSMC proliferation and the induction of apoptosis. This suggests that telomerase activity plays a critical role in vascular remodeling, particularly in the context of hypertension. [1] Genetic research has identified several loci associated with aortic root diameter, with genes such as CCDC100, HMGA2, and PDE3A being expressed in aortic tissue. [1] Additionally, SMG6, another gene expressed in aortic tissue, encodes a component of the telomerase ribonucleoprotein complex, further highlighting the link between telomere regulation and aortic structure and function. [1] The FLT1 gene, also known as vascular endothelial growth factor receptor, and circulating vascular endothelial growth factor (VEGF) levels are also relevant to vascular processes. [2]
Clinical Relevance
Abnormal aortic vascular smooth muscle cell proliferation holds significant clinical relevance due to its direct involvement in the pathogenesis and progression of a wide spectrum of cardiovascular diseases. It is a central feature of vascular remodeling seen in conditions like atherosclerosis, where it contributes to the thickening of arterial walls and the formation of atherosclerotic plaques. [3] Dysregulation of VSMC proliferation is also implicated in the development and worsening of hypertension and abdominal aortic aneurysms. [1] Genome-wide association studies have identified genetic variants linked to measures of aortic root diameter [1] and subclinical atherosclerosis phenotypes, including common carotid artery intima-media thickness (IMT), internal carotid artery IMT, coronary artery calcification (CAC), abdominal aortic calcification (AAC), and ankle-brachial index (ABI). [3] These measures are critical indicators of vascular health, reflecting the impact of VSMC behavior on arterial structure.
Social Importance
The study of aortic vascular smooth muscle cell proliferation is of considerable social importance given the global burden of cardiovascular diseases. Conditions such as hypertension, atherosclerosis, and aortic aneurysms represent leading causes of morbidity, disability, and mortality worldwide. A deeper understanding of the genetic and molecular mechanisms that drive VSMC proliferation can facilitate the identification of novel therapeutic targets and the development of biomarkers for early detection, improved risk stratification, and personalized treatment strategies. By unraveling the genetic factors that influence this attribute, researchers aim to create more effective interventions for preventing and treating these prevalent and often devastating diseases, thereby improving public health outcomes and reducing the substantial healthcare costs associated with cardiovascular care.
Statistical Power and Significance Thresholds
Research into the genetic underpinnings of aortic vascular smooth muscle cell proliferation is often constrained by statistical limitations inherent in genome-wide association studies (GWAS). Despite the utilization of a mo Genetic variations like rs982228 may influence the expression or activity of _CCNG1_, thereby modulating cell cycle control within the aortic wall.
The _MRPL57P6_ gene is identified as a pseudogene, often related to mitochondrial ribosomal proteins. While pseudogenes do not typically encode functional proteins, they can play regulatory roles, for instance, by influencing the expression of their functional parent genes or through non-coding RNA mechanisms. Mitochondrial ribosomal proteins are crucial for the synthesis of proteins within mitochondria, which are the powerhouses of the cell, responsible for energy production and various metabolic pathways. Optimal mitochondrial function is essential for the viability, function, and proliferative capacity of cells, including aortic vascular smooth muscle cells . [1], [4] Any impact of _MRPL57P6_ on mitochondrial activity could indirectly affect VSMC proliferation and overall vascular remodeling.
The rs982228 variant, by potentially influencing either _CCNG1_ or _MRPL57P6_, could contribute to the complex genetic landscape underlying aortic vascular smooth muscle cell proliferation. For example, altered _CCNG1_ activity could lead to uncontrolled VSMC growth, a hallmark of conditions like atherosclerosis and restenosis. Similarly, if _MRPL57P6_ modulates mitochondrial function, changes induced by rs982228 could impair cellular energy metabolism, influencing VSMC survival or proliferative responses. The regulation of cell proliferation is a tightly controlled process, and disruptions, even subtle ones, can have significant consequences for vascular integrity. Notably, telomerase activity, which is involved in maintaining chromosome ends, has been linked to the proliferation of vascular smooth muscle cells, with its down-regulation associated with the arrest of VSMC proliferation and induction of apoptosis. [1] Thus, variants affecting genes like _CCNG1_ and _MRPL57P6_ may contribute to the genetic predisposition for altered vascular smooth muscle cell behavior and associated aortic health attributes.
Defining Aortic Structural Attributes
The term 'aortic vascular smooth muscle cell proliferation attribute' conceptually refers to changes in the cellular composition and structure of the aorta, which are often inferred through observable and measurable characteristics of the aortic wall. While the provided research does not directly define or measure smooth muscle cell proliferation, it focuses on quantifiable attributes of the aorta that can be indicative of underlying vascular remodeling processes. Key among these are the aortic root diameter and the presence and extent of calcification within the aorta, both of which serve as indicators of arterial health and disease progression. [4]
Aortic root diameter (ARD) is a precise anatomical measurement, typically evaluated at end-diastole, specifically at the level of the aortic annulus and the sinuses of Valsalva, representing a continuous trait reflecting the size of the proximal aorta. [4] In contrast, aortic calcification, such as abdominal aortic calcification (AAC), represents a pathological attribute characterized by the deposition of calcium salts within the arterial wall. A calcified lesion is operationally defined as an area spanning at least three connected pixels with a CT attenuation greater than 130 Hounsfield Units, utilizing three-dimensional connectivity criteria. [4] These calcifications are considered a measure of subclinical atherosclerosis, a condition involving arterial wall changes that may include smooth muscle cell alterations. [4]
Measurement Approaches and Operational Definitions
The assessment of aortic structural attributes employs distinct imaging modalities to ensure precise and reproducible measurements. Aortic root diameter is commonly measured using two-dimensional echocardiography, where an experienced investigator verifies the measurements taken during quiet respiration. [4] While M-mode echocardiography is also a recognized method, it may introduce measurement errors leading to an underestimation of aortic diameter compared to two-dimensional imaging. [1] For genetic analyses, when multiple echocardiographic examinations are available, the average of all eligible measurements is often utilized to derive a stable phenotypic value. [1]
Abdominal aortic calcification (AAC) and coronary artery calcification (CAC) are quantified through multidetector Computed Tomography (MDCT) scans, with calcium measurements meticulously performed on offline workstations by trained technicians. [4] The scoring of calcification involves multiplying the area of a detected calcified lesion by a weighted CT attenuation score, which is dependent on the maximal Hounsfield Units within the lesion. This methodology represents a modification of the established Agatston Score, adapted for MDCT protocols, and provides a quantitative measure of calcification burden. [4] For genetic association studies, these quantitative phenotypes are often adjusted for various covariates such as age, sex, smoking status, diabetes, hypertension, body mass index, and lipid profiles to isolate the genetic effects. [4]
Classification and Related Terminology
The attributes of aortic structure and pathology are classified within broader frameworks of cardiovascular health and disease, particularly subclinical atherosclerosis. Aortic root diameter, as a continuous trait, can be used to identify individuals with aortic dilation, a condition that might precede more severe aortic pathologies. Measures like abdominal aortic calcification (AAC) and coronary artery calcification (CAC) are categorized as key indicators of subclinical atherosclerosis, reflecting the early stages of arterial disease before overt clinical symptoms manifest. [4] These measures contribute to a comprehensive assessment of arterial territories, alongside other indicators such as carotid intimal medial thickness (IMT) and ankle-brachial index (ABI), all of which are utilized in large-scale epidemiological and genetic studies. [4]
Terminology in this field includes specific anatomical references and diagnostic labels. "Aortic root" specifically denotes the segment of the aorta originating from the left ventricle, encompassing the aortic annulus and the sinuses of Valsalva. [4] "Subclinical atherosclerosis" refers to the presence of arterial disease without clinical symptoms, often detected through imaging modalities that quantify calcification or arterial wall thickness. [4] While the studies do not detail specific severity gradations for aortic calcification beyond the definition of a lesion, the quantitative nature of the scoring allows for a dimensional assessment of disease burden. [4]
Cellular Signaling and Regulatory Networks in Aortic VSMC Proliferation
Aortic vascular smooth muscle cell (VSMC) proliferation is a tightly regulated process influenced by a complex interplay of intracellular signaling pathways and regulatory networks. Dysregulation of these pathways can lead to conditions like abdominal aortic aneurysm (AAA) and hypertension, where uncontrolled VSMC growth contributes to vascular remodeling and disease progression. For instance, the DAB2IP gene product, a RasGAP-related protein, plays a crucial role in regulating cellular functions by coordinating both the PI3K-Akt and ASK1 pathways, which are central to cell survival and apoptosis. [5] Akt signaling, in particular, is vital for maintaining vascular homeostasis and promoting angiogenesis, and its activation can influence endothelial nitric oxide synthase, impacting overall vascular health. [6] Furthermore, the c-Jun N-terminal kinase (JNK) pathway has been implicated in the pathogenesis of abdominal aortic aneurysms, with its inhibition leading to disease regression. [7]
Another critical signaling axis involves vascular endothelial growth factor receptor 2 (VEGFR2), which mediates inflammatory angiogenesis. The protein AIP1 acts as an endogenous inhibitor of VEGFR2-mediated signaling, highlighting the intricate balance of pro- and anti-proliferative signals within the vascular system. [8] Alterations in metabolic processes can also influence VSMC behavior, as seen with phosphodiesterase 3-mediated cAMP hydrolysis. Disrupted cAMP regulation has been linked to a hypermotile phenotype in aortic VSMCs, which can contribute to diabetes-associated cardiovascular disease. [9] These interconnected molecular pathways collectively dictate the proliferative state of aortic VSMCs, influencing vascular structure and function.
Genetic and Epigenetic Modulators of Vascular Cell Fate
Genetic mechanisms significantly impact the proliferation of aortic vascular smooth muscle cells, with specific genes and their regulatory elements influencing cell growth, differentiation, and survival. Variants in genes like DAB2IP have been identified as conferring susceptibility to abdominal aortic aneurysm, suggesting a genetic predisposition to vascular pathologies involving altered VSMC behavior. [10] The expression of DAB2IP itself is differentially regulated in various tissues, indicating its critical role in maintaining cellular homeostasis. [11] Beyond individual gene functions, broader regulatory mechanisms like telomere maintenance are also pivotal.
Telomerase activity, which is responsible for elongating telomeres, is often upregulated in the aorta during conditions like hypertension and is associated with VSMC proliferation. [12] Conversely, down-regulation of telomerase activity can arrest VSMC proliferation and induce apoptosis, underscoring its role in vascular remodeling. [12] The SMG6 gene, expressed in aortic tissue, encodes a component of the telomerase ribonucleoprotein complex, which is essential for telomere replication and regulation. [13] Other genes like HMGA2, which encodes a transcriptional regulating factor with DNA-binding domains, and PDE3A are also expressed in aortic tissue and have been associated with aortic root diameter, further illustrating the complex genetic landscape governing aortic structure and function. [1]
Growth Factors and Their Systemic Impact on Vascular Health
Growth factors are crucial biomolecules that orchestrate cell proliferation, migration, and differentiation, playing a central role in vascular development, maintenance, and disease. Vascular endothelial growth factor (VEGF) is a prominent example, serving as a key mediator of angiogenesis and having measurable circulating levels influenced by genetic variants. [2] Serum VEGF concentrations are typically higher than plasma levels due to its release from platelets during clotting, highlighting the dynamic nature of its availability within the body. [2] The heritability of circulating growth factors, including VEGF, indicates a genetic component to their levels and potential impact on vascular function. [14]
VEGF is implicated in various physiological and pathological processes, from angiogenesis in ischemic limbs to its correlation with cancer recurrence . [15], [16] Its receptor, FLT1 (also known as VEGFR1), is another critical component of the vascular system, emphasizing the importance of VEGF signaling in vascular biology. [2] Beyond VEGF, other factors like TGF-beta1 also contribute to the complex network regulating vascular smooth muscle cell behavior, with their concentrations linked to disease states. [17] These growth factors and their receptors represent key biomolecules whose balanced activity is essential for maintaining vascular homeostasis and preventing abnormal VSMC proliferation.
Pathophysiological Processes in Aortic Disease
The proliferation of aortic vascular smooth muscle cells is a critical component of several pathophysiological processes affecting the aorta, including the development and progression of abdominal aortic aneurysms and hypertension-related vascular remodeling. Abdominal aortic aneurysm, for instance, involves pathological changes in the aortic wall, where altered VSMC behavior contributes to structural weakening and dilation. [10] Hypertension can induce vascular remodeling, a process where changes in VSMC proliferation and apoptosis contribute to alterations in vessel wall thickness and stiffness. [12]
Neural cell adhesion molecule (NCAM), a cardioprotective factor, is upregulated by metabolic stress and contributes to left ventricular wall thickness in hypertensive families, suggesting its role in cardiac and potentially vascular responses to stress . [18], [19] The presence of NCAM in developing and transplanted human hearts further underscores its significance in cardiac and vascular tissue development and remodeling. [20] These disease mechanisms represent disruptions of normal homeostatic processes, where compensatory responses, such as altered VSMC proliferation, can ultimately contribute to disease progression rather than resolution. Understanding these tissue and organ-level effects is paramount for comprehending the systemic consequences of dysregulated aortic VSMC proliferation.
Growth Factor Signaling and Intracellular Transduction
Aortic vascular smooth muscle cell proliferation is significantly influenced by extracellular growth factor signaling, which initiates complex intracellular cascades. Vascular endothelial growth factor (VEGF) plays a critical role, with its carboxyl-terminal domain being essential for its mitogenic potency, thereby driving cell division and contributing to processes like angiogenesis and vasculogenesis. [21] Upon receptor activation, pathways such as the PI3K-Akt cascade are crucial for vascular homeostasis and angiogenesis, with Akt signaling also activating nitric oxide synthase in endothelial cells. [22] The protein DAB2IP serves as a key coordinator, modulating both the PI3K-Akt and ASK1 pathways to fine-tune cell survival and apoptosis, directly impacting cellular proliferation. [5] Additionally, the c-Jun N-terminal kinase (JNK) pathway contributes to vascular remodeling, as its inhibition has been shown to induce regression of abdominal aortic aneurysms, suggesting its involvement in processes that promote pathological proliferation. [7]
Cyclic Nucleotide Metabolism and Cell Cycle Control
The regulation of aortic vascular smooth muscle cell proliferation is also intricately linked to cyclic nucleotide metabolism and mechanisms that govern the cell cycle. Altered phosphodiesterase 3 (PDE3)-mediated cAMP hydrolysis, for example, contributes to a hypermotile phenotype in obese rat aortic vascular smooth muscle cells, illustrating how metabolic regulation impacts cell behavior and proliferation. [9] PDE3A, a cGMP-inhibited phosphodiesterase, is expressed in aortic tissue, highlighting its specific role in vascular biology. [1] Furthermore, telomerase activity, facilitated by telomerase reverse transcriptase (TERT) in elongating telomeres, is a crucial regulator of cell proliferation; its upregulation in the aorta of spontaneous hypertensive rats promotes vascular smooth muscle cell proliferation, while its downregulation halts proliferation and induces apoptosis. [12] This interplay between cyclic nucleotide signaling and telomere maintenance pathways provides essential control over VSMC growth and survival.
Transcriptional Regulation and Adhesion Molecules
Transcriptional regulation is a fundamental determinant of the proliferative phenotype in aortic vascular smooth muscle cells, involving specific transcription factors and their cofactors. HMGA2, a high mobility group AT-hook 2 protein, acts as a key transcriptional regulating factor, influencing the gene expression profiles that dictate cell growth and differentiation. [1] The DAB2IP gene itself exhibits differential regulation in various tissues, indicating that its transcriptional control is critical for normal cellular function and that its dysregulation can contribute to abnormal proliferation. [11] Moreover, GATA transcription factors, supported by cofactors such as FOG-2, are vital for vascular development and function, with GATA3 specifically mediating Tie2 expression in large vessel endothelial cells, thereby influencing vascular integrity and potentially VSMC behavior. [23] Beyond transcriptional control, cell adhesion molecules like NCAM (Neural Cell Adhesion Molecule) are crucial for regulating cell-cell interactions and are upregulated by metabolic stress, contributing to the broader context of vascular remodeling and potentially influencing VSMC proliferation and migration. [24]
Network Integration and Disease Relevance
The proliferation of aortic vascular smooth muscle cells is not governed by isolated pathways but rather by a complex network of integrated signaling cascades and regulatory mechanisms, whose dysregulation is central to several vascular diseases. DAB2IP exemplifies this pathway crosstalk by coordinating both the PI3K-Akt and ASK1 pathways, illustrating how cellular survival and apoptosis are precisely controlled through interconnected signaling hubs. [5] In the context of disease, telomerase activation represents a key compensatory mechanism observed in genetic hypertension, directly driving vascular smooth muscle cell proliferation and contributing to pathological vascular remodeling. [12] Similarly, altered PDE3-mediated cAMP hydrolysis in obese rat VSMCs has significant implications for diabetes-associated cardiovascular disease, linking metabolic dysregulation to pathological VSMC behavior. [9] The relevance of these integrated pathways extends to conditions like abdominal aortic aneurysms, where a genetic variant within the DAB2IP gene confers susceptibility [10] and the therapeutic targeting of pathways like JNK can induce aneurysm regression. [7] These examples highlight how understanding the systems-level integration and dysregulation of these molecular mechanisms is crucial for identifying therapeutic targets to manage aortic vascular smooth muscle cell proliferation in cardiovascular diseases.
Clinical Relevance
Aortic vascular smooth muscle cell (VSMC) proliferation is a fundamental cellular process implicated in the remodeling and pathology of the aorta and other major arteries. While direct clinical measurement of this proliferation attribute is not routinely performed, its regulation, particularly through mechanisms like telomerase activity, is critical for understanding vascular health and disease progression. Changes in VSMC proliferation contribute to structural alterations in the arterial wall, which manifest as clinically measurable phenotypes with significant implications for patient care.
Prognostic and Risk Stratification Implications
The regulation of aortic vascular smooth muscle cell proliferation holds significant prognostic value, particularly through its influence on vascular remodeling. Telomerase activity, which is associated with vascular smooth muscle cell proliferation and apoptosis, plays a critical role in vascular remodeling, especially in the context of hypertension. [1] This remodeling can lead to altered cardiac structures, such as an increased aortic root diameter, which is an intermediate phenotype strongly predictive of adverse clinical cardiovascular outcomes, including congestive heart failure, stroke, and overall mortality. [1] Therefore, understanding the factors that modulate VSMC proliferation can inform the long-term prognosis for individuals at risk of progressive aortic disease.
Furthermore, insights into the molecular pathways governing VSMC proliferation can facilitate personalized risk stratification. Genetic variants impacting the regulation of vascular smooth muscle cell proliferation, possibly through mechanisms like telomerase activity or other related genes (e.g., CCDC100, HMGA2, PDE3A associated with aortic root diameter), could serve as biomarkers. [1] Identifying individuals with genetic predispositions to aberrant VSMC proliferation would enable early identification of high-risk patients, allowing for targeted prevention strategies and potentially influencing treatment selection before overt clinical disease develops.
Diagnostic and Monitoring Strategies
While no direct diagnostic test for the aortic vascular smooth muscle cell proliferation attribute is outlined, its clinical impact is indirectly assessed through various imaging modalities. Echocardiographic measurements of aortic root diameter are a cornerstone in evaluating aortic health and are influenced by underlying cellular processes like VSMC proliferation contributing to vascular remodeling . [1], [4] Alterations in aortic root size are crucial indicators, serving as intermediate phenotypes for a range of cardiovascular diseases.
Monitoring strategies for aortic pathologies implicitly involve tracking the consequences of altered VSMC proliferation. Serial echocardiographic assessments of aortic root dimensions can monitor the progression of aortic remodeling and dilation, providing valuable information on disease trajectory. [1] Similarly, measures of subclinical atherosclerosis, such as common carotid artery intima-media thickness (IMT) and abdominal aortic calcification (AAC), are routinely monitored. These measures, influenced by complex vascular cell biology including VSMC dynamics, serve as indicators of arterial health and potential disease progression, with genetic associations identified for various markers like FGF1 for AAC and MEF2C and THBS2 for common carotid artery IMT. [4]
Associations with Comorbidities and Disease Phenotypes
The attribute of aortic vascular smooth muscle cell proliferation is intrinsically linked to several cardiovascular comorbidities and disease phenotypes. It is implicated in conditions such as hypertension, where an upregulation of telomerase activity in the aorta has been observed, contributing to vascular remodeling. [1] This remodeling, often characterized by increased aortic root diameter, is a significant risk factor for the development of congestive heart failure, stroke, and increased mortality. [1]
Moreover, aortic root size, an indicator of vascular remodeling that can be influenced by smooth muscle cell proliferation, functions as an important intermediate phenotype for various clinical cardiovascular disease outcomes. [1] Genetic variants have been identified that are associated with subclinical atherosclerosis measures across different arterial territories, including the ankle-brachial index (ABI), common carotid artery IMT, and coronary artery calcification. [4] These widespread vascular changes suggest a common underlying pathophysiology that may involve dysregulated smooth muscle cell behavior and proliferation, highlighting the attribute's broad relevance across the spectrum of arterial diseases.
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs982228 | MRPL57P6 - CCNG1 | aortic vascular smooth muscle cell proliferation attribute |
Frequently Asked Questions About Aortic Vascular Smooth Muscle Cell Proliferation Attribute
These questions address the most important and specific aspects of aortic vascular smooth muscle cell proliferation attribute based on current genetic research.
1. My family has heart problems; will my arteries be affected too?
Yes, genetics play a significant role in your risk for conditions like atherosclerosis and aneurysms. Genes like CCDC100 and HMGA2 are linked to aortic structure, so a family history means you might inherit some of those predispositions. Understanding your family's health can help you discuss preventative steps with your doctor.
2. Does getting older automatically mean my arteries get worse?
While aging is a factor, genetic predispositions also influence how your arteries change over time. For example, some individuals may have genes that affect cell proliferation in the aorta, making them more susceptible to age-related vascular remodeling. Regular check-ups and a healthy lifestyle can help mitigate these risks.
3. I have high blood pressure; does that harm my artery cells?
Yes, high blood pressure is a major driver of changes in your artery cells. It can cause aortic vascular smooth muscle cells to proliferate more, contributing to conditions like hypertension and thickening of arterial walls. Research shows that telomerase activity, partly influenced by genes like SMG6, is upregulated in hypertension, impacting these cells.
4. Can exercising regularly protect my arteries from problems?
Regular exercise is generally beneficial for overall vascular health. While the direct genetic pathways linking exercise to specific smooth muscle cell proliferation aren't detailed, by managing cardiovascular risk factors like blood pressure and cholesterol, exercise can indirectly help maintain healthy arterial structure and function and reduce the stimuli that cause cells to proliferate.
5. Does what I eat affect how healthy my blood vessels are?
While the article doesn't directly link specific diets to vascular smooth muscle cell proliferation, your diet significantly impacts overall cardiovascular health. Poor dietary choices can contribute to conditions like atherosclerosis, which involves abnormal smooth muscle cell behavior. Eating a balanced diet can help reduce the risk factors that promote this proliferation.
6. Can everyday stress make my arteries unhealthy?
The article doesn't directly discuss stress as a stimulus for aortic smooth muscle cell proliferation. However, chronic stress is known to contribute to high blood pressure and other cardiovascular risk factors, which do promote these cellular changes. Managing stress is important for overall heart and vascular health, helping to reduce the burden on your arteries.
7. What do my doctor's artery measurements actually mean for me?
Measurements like aortic root diameter, carotid artery thickness (IMT), or ankle-brachial index (ABI) are important indicators of your vascular health. These reflect changes in your artery walls, including those caused by smooth muscle cell proliferation, and can signal conditions like atherosclerosis or aneurysms. Genetic factors can influence these measurements, too.
8. What can I do to prevent my arteries from getting thick?
Preventing arterial thickening, often linked to smooth muscle cell proliferation, involves managing cardiovascular risk factors. This includes monitoring blood pressure, cholesterol, and blood sugar, and adopting a healthy lifestyle with regular exercise and a balanced diet. While genetics play a role, lifestyle choices can significantly influence your risk.
9. Why do some people get artery problems and others don't, even with similar lifestyles?
A significant part of this difference lies in genetics. Even with similar lifestyles, individuals have varying genetic predispositions influencing how their aortic smooth muscle cells behave. Genes like CCDC100, HMGA2, and PDE3A are associated with differences in aortic structure, explaining why some are more susceptible than others.
10. Could a DNA test tell me if I'm at risk for bad arteries?
Yes, genetic research has identified specific variants linked to measures of aortic health, like aortic root diameter and subclinical atherosclerosis phenotypes. A DNA test could reveal if you carry some of these genetic predispositions, but it's important to remember that these are just risk factors, not definitive diagnoses, and lifestyle still plays a crucial role.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
[1] Vasan, R.S. et al. "Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data." JAMA, 2009.
[2] Ikram, M. Kamran et al. "Four novel Loci (19q13, 6q24, 12q24, and 5q14) influence the microcirculation in vivo." PLoS Genetics, vol. 6, no. 11, 2010, pp. e1001183.
[3] O'Donnell, C.J. et al. "Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study." BMC Medical Genetics, 2007.
[4] Wineinger, N.E. et al. "Genome-wide joint SNP and CNV analysis of aortic root diameter in African Americans: the HyperGEN study." BMC Medical Genomics, 2011.
[5] Xie, Dong et al. "DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis." Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 47, 2009, pp. 19878–19883.
[6] Dimmeler, S., et al. "Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation." Nature, vol. 399, no. 6736, 1999, pp. 601-605.
[7] Yoshimura, K., et al. "Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase." Nat Med, vol. 11, no. 12, 2005, pp. 1330-1338.
[8] Zhang, Hong et al. "AIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in mice." Journal of Clinical Investigation, vol. 118, no. 12, 2008, pp. 3904–3916.
[9] Netherton, Sarah J. et al. "Altered phosphodiesterase 3-mediated cAMP hydrolysis contributes to a hypermotile phenotype in obese jcr: la-cp rat aortic vascular smooth muscle cells: implications for diabetes-associated cardiovascular disease." Diabetes, vol. 51, no. 4, 2002, pp. 1194–1200.
[10] Gretarsdottir, Sif, et al. "Genome-Wide Association Study Identifies a Sequence Variant within the DAB2IP Gene Conferring Susceptibility to Abdominal Aortic Aneurysm." Nature Genetics, vol. 42, no. 8, 2010, pp. 692–97.
[11] Chen, Hsin-Fu et al. "Differential regulation of the human gene DAB2IP in normal and malignant prostatic epithelia: cloning and characterization." Genomics, vol. 79, no. 4, 2002, pp. 573–581.
[12] Cao, Yong et al. "Telomerase activation causes vascular smooth muscle cell proliferation in genetic hypertension." FASEB Journal, vol. 16, no. 1, 2002, pp. 96–98.
[13] Snow, Brian E. et al. "Functional conservation of the telomerase protein Est1p in humans." Current Biology, vol. 13, no. 8, 2003, pp. 698–704.
[14] Pantsulaia, Iuri et al. "Heritability of circulating growth factors involved in the angiogenesis in healthy human population." Cytokine, vol. 27, no. 4, 2004, pp. 152–158.
[15] Isner, Jeffrey M. et al. "Clinical evidence of angiogenesis after arterial gene transfer of ph_VEGF_165 in patient with ischaemic limb." Lancet, vol. 348, no. 9024, 1996, pp. 370–374.
[16] Nishimura, Ryo et al. "Higher plasma vascular endothelial growth factor levels correlate with menopause, overexpression of p53, and recurrence of breast cancer." Breast Cancer, vol. 10, no. 2, 2003, pp. 120–128.
[17] Moon, Hee-Soo et al. "Concentration of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1) in the serum of patients with cervical cancer: prediction of response." International Journal of Gynecological Cancer, vol. 10, no. 2, 2000, pp. 151–156.
[18] Nagao, Kenji et al. "Neural cell adhesion molecule is a cardioprotective factor up-regulated by metabolic stress." Journal of Molecular and Cellular Cardiology, vol. 48, no. 6, 2010, pp. 1157–1168.
[19] Arnett, Donna K. et al. "Genetic variation in NCAM1 contributes to left ventricular wall thickness in hypertensive families." Circulation Research, vol. 108, no. 6, 2011, pp. 741–747.
[20] Gordon, Leslie et al. "Myocardial localization and isoforms of neural cell adhesion molecule (N-CAM) in the developing and transplanted human heart." Journal of Clinical Investigation, vol. 86, no. 4, 1990, pp. 1293–1300.
[21] Keyt, Bruce A., et al. "The carboxyl-terminal domain (111–165) of vascular endothelial growth factor is critical for its mitogenic potency." J Biol Chem, vol. 271, no. 13, 1996, pp. 7788-7795.
[22] Shiojima, Ichiro, and Kenneth Walsh. "Role of Akt signaling in vascular homeostasis and angiogenesis." Circ Res, vol. 90, no. 12, 2002, pp. 1243-1250.
[23] Tevosian, Stephen G., et al. "FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium." Cell, vol. 101, no. 7, 2000, pp. 729-739.
[24] Rutishauser, Urs, et al. "The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions." Science, vol. 240, no. 4848, 1988, pp. 53-57.